目次

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook

2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations

3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation

4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities

5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis

6. JAPAN HOST CELL PROTEIN TESTING MARKET, BY TYPE (USD MILLION)
6.1. PCR-Based Assays
6.2. ELISA-based Assays
6.3. Mass Spectrometry-Based Assays
6.4. Others

7. JAPAN HOST CELL PROTEIN TESTING MARKET, BY END USER (USD MILLION)
7.1. Contract Research Organizations
7.2. Biopharmaceutical Companies
7.3. Others

8. COMPETITIVE LANDSCAPE
8.1. Overview
8.2. Competitive Analysis
8.3. Market share Analysis
8.4. Major Growth Strategy in the Host Cell Protein Testing Market
8.5. Competitive Benchmarking
8.6. Leading Players in Terms of Number of Developments in the Host Cell Protein Testing Market
8.7. Key developments and growth strategies
8.7.1. New Product Launch/Service Deployment
8.7.2. Merger & Acquisitions
8.7.3. Joint Ventures
8.8. Major Players Financial Matrix
8.8.1. Sales and Operating Income
8.8.2. Major Players R&D Expenditure. 2023

9. COMPANY PROFILES
9.1. WuXi AppTec
9.1.1. Financial Overview
9.1.2. Products Offered
9.1.3. Key Developments
9.1.4. SWOT Analysis
9.1.5. Key Strategies
9.2. GenScript
9.2.1. Financial Overview
9.2.2. Products Offered
9.2.3. Key Developments
9.2.4. SWOT Analysis
9.2.5. Key Strategies
9.3. Sartorius
9.3.1. Financial Overview
9.3.2. Products Offered
9.3.3. Key Developments
9.3.4. SWOT Analysis
9.3.5. Key Strategies
9.4. MilliporeSigma
9.4.1. Financial Overview
9.4.2. Products Offered
9.4.3. Key Developments
9.4.4. SWOT Analysis
9.4.5. Key Strategies
9.5. Celerion
9.5.1. Financial Overview
9.5.2. Products Offered
9.5.3. Key Developments
9.5.4. SWOT Analysis
9.5.5. Key Strategies
9.6. BioRad Laboratories
9.6.1. Financial Overview
9.6.2. Products Offered
9.6.3. Key Developments
9.6.4. SWOT Analysis
9.6.5. Key Strategies
9.7. Abcam
9.7.1. Financial Overview
9.7.2. Products Offered
9.7.3. Key Developments
9.7.4. SWOT Analysis
9.7.5. Key Strategies
9.8. Invitrogen
9.8.1. Financial Overview
9.8.2. Products Offered
9.8.3. Key Developments
9.8.4. SWOT Analysis
9.8.5. Key Strategies
9.9. Promega
9.9.1. Financial Overview
9.9.2. Products Offered
9.9.3. Key Developments
9.9.4. SWOT Analysis
9.9.5. Key Strategies
9.10. Roche
9.10.1. Financial Overview
9.10.2. Products Offered
9.10.3. Key Developments
9.10.4. SWOT Analysis
9.10.5. Key Strategies
9.11. Charles River Laboratories
9.11.1. Financial Overview
9.11.2. Products Offered
9.11.3. Key Developments
9.11.4. SWOT Analysis
9.11.5. Key Strategies
9.12. Merck
9.12.1. Financial Overview
9.12.2. Products Offered
9.12.3. Key Developments
9.12.4. SWOT Analysis
9.12.5. Key Strategies
9.13. PeproTech
9.13.1. Financial Overview
9.13.2. Products Offered
9.13.3. Key Developments
9.13.4. SWOT Analysis
9.13.5. Key Strategies
9.14. Thermo Fisher Scientific
9.14.1. Financial Overview
9.14.2. Products Offered
9.14.3. Key Developments
9.14.4. SWOT Analysis
9.14.5. Key Strategies
9.15. Lonza
9.15.1. Financial Overview
9.15.2. Products Offered
9.15.3. Key Developments
9.15.4. SWOT Analysis
9.15.5. Key Strategies

10. APPENDIX
10.1. References
10.2. Related Reports

LIST OF TABLES
TABLE 1. LIST OF ASSUMPTIONS
TABLE 2. JAPAN HOST CELL PROTEIN TESTING MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD BILLIONS)
TABLE 3. JAPAN HOST CELL PROTEIN TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
TABLE 4. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
TABLE 5. ACQUISITION/PARTNERSHIP

LIST OF FIGURES
FIGURE 1. MARKET SYNOPSIS
FIGURE 2. JAPAN HOST CELL PROTEIN TESTING MARKET ANALYSIS BY TYPE
FIGURE 3. JAPAN HOST CELL PROTEIN TESTING MARKET ANALYSIS BY END USER
FIGURE 4. KEY BUYING CRITERIA OF HOST CELL PROTEIN TESTING MARKET
FIGURE 5. RESEARCH PROCESS OF MRFR
FIGURE 6. DRO ANALYSIS OF HOST CELL PROTEIN TESTING MARKET
FIGURE 7. DRIVERS IMPACT ANALYSIS: HOST CELL PROTEIN TESTING MARKET
FIGURE 8. RESTRAINTS IMPACT ANALYSIS: HOST CELL PROTEIN TESTING MARKET
FIGURE 9. SUPPLY / VALUE CHAIN: HOST CELL PROTEIN TESTING MARKET
FIGURE 10. HOST CELL PROTEIN TESTING MARKET, BY TYPE, 2024 (% SHARE)
FIGURE 11. HOST CELL PROTEIN TESTING MARKET, BY TYPE, 2019 TO 2035 (USD Billions)
FIGURE 12. HOST CELL PROTEIN TESTING MARKET, BY END USER, 2024 (% SHARE)
FIGURE 13. HOST CELL PROTEIN TESTING MARKET, BY END USER, 2019 TO 2035 (USD Billions)
FIGURE 14. BENCHMARKING OF MAJOR COMPETITORS